Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL
Neurodegenerative Diseases · 2019 · 19 (1) · 35-42
DOI: 10.1159/000500166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurodegenerative Diseases, online erschienen am 18.06.2019. Verfasst von Xiangyu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Mutation, Missense, Point Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Background
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an autosomal-dominant, inherited, systemic, vascular disorder primarily involving the small arteries. It is characterized by migraine, recurrent ischemic strokes, cognitive decline, and dementia. Mutations in the Notch receptor 3 gene (NOTCH3) and the HtrA serine peptidase 1 gene (HTRA1) are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p13.12, is the most common disease-causing gene in CADASIL.
Objective
To investigate genetic causes in 2 unrelated Han-Chinese patients with presentations strongly suggestive of CADASIL.
Methods
Exome sequencing was performed on both patients and potential pathogenic mutations were validated by Sanger sequencing.
Results
This study reports on 2 unrelated Han-Chinese patients with presentations strongly suggestive of CADASIL, identifying that NOTCH3 mutations were the genetic cause. A common mutation, c.268C>T (p.Arg90Cys), and a novel mutation, c.331G>T (p.Gly111Cys) in the NOTCH3 gene, were detected and confirmed in the patients, respectively, and were predicted to be deleterious based on bioinformation analyses.
Conclusions
We identified 2 NOTCH3 mutations as likely genetic causes for CADASIL in these 2 patients. Our findings broaden the mutational spectrum of the NOTCH3 gene accountable for CADASIL. Clinical manifestations supplemented with molecular genetic analyses are critical for accurate diagnosis, the provision of genetic counseling, and the development of therapies for CADASIL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
- Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Radiology, the Third Xiangya Hospital, Central South University, Changsha, China.
- Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, China, yuanlamei229@163.com.
Zitieren
APA
Chen, X., Deng, S., Xu, H., Hou, D., Hu, P., Yang, Y., Wen, J., Deng, H., & Yuan, L. (2019). Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL. Neurodegenerative Diseases, 19(1), 35-42. https://doi.org/10.1159/000500166
Vancouver
Chen X, Deng S, Xu H, Hou D, Hu P, Yang Y, et al. Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL. Neurodegenerative Diseases. 2019;19(1):35-42. doi:10.1159/000500166
BibTeX
@article{Chen2019,
author = {Chen, Xiangyu and Deng, Sheng and Xu, Hongbo and Hou, Deren and Hu, Pengzhi and Yang, Yan and Wen, Jie and Deng, Hao and Yuan, Lamei},
title = {Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL},
journal = {Neurodegenerative Diseases},
year = {2019},
volume = {19},
number = {1},
pages = {35--42},
doi = {10.1159/000500166}
}
EUVIMED